Serial No. 114-153: Combatting Superbugs: U.S. Public Health Responses to Antibiotic Resistance, Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, Second Session, June 14, 2016 [open pdf - 2MB]
This is the June 14, 2016 hearing on "Combatting Superbugs: U.S. Public Health Responses to Antibiotic Resistance" held before the House of Representatives Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. From the opening statement of Committee Chairman Fred Upton: "So today, we gather to discuss the U.S. public health response to antibiotic resistance in light of the recent discovery of a new superbug. This superbug gene was first discovered by Chinese and British researchers in pigs, raw pork, and in a small number of folks in China in November of last year, but a recent case of course of the woman in Pennsylvania with the E. coli is the first discovery of this rare gene known as MCR here in the U.S. [...] The continuing evolution of bacteria, the overprescription of antibiotics, and the lack of new antibiotic development have all contributed to the problem. Our understanding of the MCR-1 gene is growing by the day, but there are still many questions that remain to be answered before we can be assured that we are doing everything that we can to protect the American people from this superbug and future challenges that arise from antibiotic resistance". Statements, letters, and materials submitted for the record include those of the following: Beth Bell, Janet Woodcock, Richard J. Hatchett, and Dennis M. Dixon.
Serial Number 114-153; Serial No. 114-153
Government Publishing Office: http://www.gpo.gov/